Programming T-Cells with Synthetic Immunology to Overcome Solid Tumor Barriers
Time: 3:30 pm
day: Post-Conference Solid Tumor Focus Day
Details:
- Achieving efficacy in solid tumor cell therapy requires addressing challenges of insufficient specificity and potency of conventional designs
- ArsenalBio has developed technologies, manufacturing, and regulatory know-how to make T-cell products with large, multi-functional transgenes to address these challenges
- We are advancing a pipeline of therapies for solid tumor indications
